2017
DOI: 10.1111/1744-9987.12499
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Apheresis in Immunologic Renal and Neurological Diseases

Abstract: Since the mid 1970s, when membrane modules became available, plasma separation techniques have gained in importance especially in the past few years. The advantages of this method are a complete separation of the corpuscular components from the plasma and due to increased blood flow rate and higher efficacy. Systemic autoimmune diseases based on an immune pathogenesis produce autoantibodies and circulating immune complexes, which cause inflammation in the tissues of various organs. In most cases, these disease… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
15
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 89 publications
0
15
0
1
Order By: Relevance
“…Critical parameters, like the optimal quantity of capsid antigen required to efficiently capture anti-AAV Ig, will also need to be defined. Furthermore, it would be useful to identify protocols in which the current technology is combined with an immunomodulatory regimen to increase the efficiency of the approach and thus achieve clearance of anti-AAV antibodies more rapidly than with plasmapheresis alone 45 . While the current proof-of-concept work demonstrated the feasibility of the approach in the context of one specific serotype, the development of column containing multiple AAV serotypes, therefore with different specificities, could potentially represent a universal device for antibodies directed to different AAVs.…”
Section: Discussionmentioning
confidence: 99%
“…Critical parameters, like the optimal quantity of capsid antigen required to efficiently capture anti-AAV Ig, will also need to be defined. Furthermore, it would be useful to identify protocols in which the current technology is combined with an immunomodulatory regimen to increase the efficiency of the approach and thus achieve clearance of anti-AAV antibodies more rapidly than with plasmapheresis alone 45 . While the current proof-of-concept work demonstrated the feasibility of the approach in the context of one specific serotype, the development of column containing multiple AAV serotypes, therefore with different specificities, could potentially represent a universal device for antibodies directed to different AAVs.…”
Section: Discussionmentioning
confidence: 99%
“…In parallel, efforts are underway to develop improved dialytic technology. In some nephrological diseases, the etiology is autoimmune or immunologically related, 2,25 such as rapidly progressing glomerulonephritis, Goodpasture's, Henoch‐Schӧnlein purpura nephritis, focal segmental glomerulosclerosis, crescentric nephritis, lupus nephritis, ANCA‐associated glomerulonephritis, immune complex nephritis, and transplantation rejection. Efforts to preserve kidney function are critical to avoid end‐stage disease.…”
Section: Reflections On Renal Supportmentioning
confidence: 99%
“…Therapeutic plasma exchange is indicated in the management of various hematological diseases. For most of these diseases, clear pathogenetic mechanisms of the disease are understood, and there are well‐defined criteria with regard to the therapy . Most medical management of immunohematological disorders requires the use of TA, serological immunomodulation, and classical pharmacological immunosuppression with steroids, cytotoxic agents, and antimetabolites, where overall therapy is individually tailored to the needs of the patient.…”
Section: Hematological Diseasesmentioning
confidence: 99%